very true. I have transitioned to investing in management more so than the product when it comes to the OTC. Has been doing well for me so far. haha. From my interactions, Stiles seems like a genuinely stand up guy and has the motivation and business contacts to make this a successful company. They are laying a strong groundwork with there niche practitioners only market sector and creating a CBD marketplace, which could be huge if implemented and managed correctly. Lots of developments to be excited about over the next year. The O/S is still very low for an OTC company...especially one in the CBD sector. Good luck and i hope you get the best entry price...I just wouldn't want to miss out because once the dilution stops this will bounce back pretty hard IMO and if it comes with a PR that convertible debt has been serviced then this could gap up at some point. Time will tell.
News 
Market Data 
Discover 
